DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW MAGNESIUM / LOW CALCIUM 4.25% DEXTROSE and attached...
FDA Drug Recall #D-0608-2024 — Class II — June 18, 2024
Recall Summary
| Recall Number | D-0608-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 18, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Medical Care Holdings, Inc. |
| Location | Waltham, MA |
| Product Type | Drugs |
| Quantity | 183 cases |
Product Description
DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW MAGNESIUM / LOW CALCIUM 4.25% DEXTROSE and attached stay "safe Exchange Set, 2500mL (Approx. 50 mL excess), Single Dose Container Sterile and Non-Pyrogenic, For Intraperitoneal Administration Only, Fresenius Medical Care NA Waltham, MA 02451, 1-800-323-5188 NDC 49230-212-94
Reason for Recall
This product is being recalled due to the tube weld failure presents itself as a slow leak and can be difficult to detect.
Distribution Pattern
Nationwide
Lot / Code Information
24AU03024, exp. date 07/31/2025
Other Recalls from Fresenius Medical Care Holdings, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0490-2025 | Class II | 0.9% Sodium Chloride Injection, USP, Flexible P... | May 27, 2025 |
| D-0218-2024 | Class II | DELFLEX Peritoneal Dialysis Solution in Biofine... | Dec 28, 2023 |
| D-0777-2023 | Class II | Sodium Chloride 0.9% Injection, USP, 1000 mL ba... | May 23, 2023 |
| D-0075-2023 | Class II | 0.9% Sodium Chloride Injection, USP, Each 100 m... | Nov 22, 2022 |
| D-0015-2023 | Class II | 0.9% Sodium Chloride Injection, USP, Each 100 m... | Oct 11, 2022 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.